Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Cash Flow Reinvestment Rate
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A cash flow reinvestment rate. Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has a Cash Flow Reinvestment Rate of 3.98x as of December 2024, reinvesting CN¥503.43 Million (capex CN¥115.96 Million plus investments CN¥-387.47 Million) from operating cash flow of CN¥126.49 Million. Explore debt repayment capacity of Jiangsu Canopus Wisdom Medical Technolog to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)
Cash flow reinvestment rate of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A from 2020 to 2024. Historical reinvestment intensity for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A across 5 annual periods. Explore Jiangsu Canopus Wisdom Medical Technolog capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Cash Flow Reinvestment Rate by Year (2020–2024)
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A cash flow reinvestment rate by year from 2020 to 2024. Year-by-year capital reinvestment analysis for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A. For the full cash flow conversion analysis, see 301290 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.98x | CN¥503.43 Million | CN¥126.49 Million | CN¥115.96 Million | ▲ +2.0% |
| 2023 | 3.90x | CN¥636.51 Million | CN¥163.13 Million | CN¥111.46 Million | ▲ +162.4% |
| 2022 | 1.49x | CN¥140.72 Million | CN¥94.63 Million | CN¥74.35 Million | ▲ +142.4% |
| 2021 | 0.61x | CN¥100.25 Million | CN¥163.45 Million | CN¥95.67 Million | ▼ -76.8% |
| 2020 | 2.64x | CN¥301.35 Million | CN¥114.07 Million | CN¥25.43 Million | — |